Log in
Enquire now
‌

US Patent 7144863 GLP-1 formulations with protracted time action

Patent 7144863 was granted and assigned to Eli Lilly and Company on December, 2006 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
1
Current Assignee
Eli Lilly
Eli Lilly
1
Date Filed
May 21, 2002
1
Date of Patent
December 5, 2006
1
Patent Application Number
10477034
1
Patent Citations Received
‌
US Patent 11840559 Glucagon-receptor selective polypeptides and methods of use thereof
3
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
7144863
1
Patent Primary Examiner
‌
Anish Gupta
1

Find more entities like US Patent 7144863 GLP-1 formulations with protracted time action

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.